ResApp Health Ltd (RAP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ResApp Health Ltd (RAP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11537
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It’s digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseases. The company develops diagnostic tools that require a smartphone. ResApp has license from The University of Queensland for technology that uses sound to diagnose respiratory diseases including upper respiratory tract infections, pneumonia, bronchitis, asthma and chronic obstructive pulmonary disease (COPD). Markets for ResApp’s technology include emergency department and regular clinic use by healthcare providers, at-home use by consumers and tele-health use through partnerships with tele-health service providers. ResApp is headquartered in Brisbane, Queensland, Australia.

ResApp Health Ltd (RAP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ResApp Health Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ResApp Health Ltd, Medical Devices Deals, 2012 to YTD 2018 9
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Narhex Life Sciences to Raise USD3.1 Million in Public Offering of Shares 11
Narhex Life Sciences to Raise USD0.04 Million in Private Placement of Shares 12
Narhex Life Sciences to Raise USD0.7 Million in Private Placement of Shares 13
Narhex Life Sciences Completes Private Placement Of Shares For US$0.5 Million 14
ResApp Health Ltd – Key Competitors 15
ResApp Health Ltd – Key Employees 16
ResApp Health Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
ResApp Health Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ResApp Health Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ResApp Health Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
ResApp Health Ltd, Medical Devices Deals, 2012 to YTD 2018 9
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Narhex Life Sciences to Raise USD3.1 Million in Public Offering of Shares 11
Narhex Life Sciences to Raise USD0.04 Million in Private Placement of Shares 12
Narhex Life Sciences to Raise USD0.7 Million in Private Placement of Shares 13
Narhex Life Sciences Completes Private Placement Of Shares For US$0.5 Million 14
ResApp Health Ltd, Key Competitors 15
ResApp Health Ltd, Key Employees 16
ResApp Health Ltd, Subsidiaries 17

List of Figures
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ResApp Health Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ResApp Health Ltd (RAP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Emirates Telecommunications Group:戦略・SWOT・企業財務分析
    The Emirates Telecommunications Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Telecommunications Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Sinclair Oil Corporation:企業の戦略・SWOT・財務情報
    Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • NCC Group PLC (NCC):企業の財務・戦略的SWOT分析
    NCC Group PLC (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • RattanIndia Power Ltd (RTNPOWER):企業の財務・戦略的SWOT分析
    RattanIndia Power Ltd (RTNPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Oregon Health & Science University-製薬・医療分野:企業M&A・提携分析
    Summary Oregon Health & Science University (OHSU), a subsidiary of Oregon State University is an academic health center that provides medical education, research, patient care and community services. The center’s educational institute offers undergraduate and graduate courses in anesthesiology, derm …
  • McCain Foods Ltd:戦略・SWOT・企業財務分析
    McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary McCain Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Finning International Inc (FTT):企業の財務・戦略的SWOT分析
    Finning International Inc (FTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Mercuria Energy Group Ltd:企業のM&A・事業提携・投資動向
    Mercuria Energy Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mercuria Energy Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Turkiye Halk Bankasi AS:企業の戦略・SWOT・財務分析
    Turkiye Halk Bankasi AS - Strategy, SWOT and Corporate Finance Report Summary Turkiye Halk Bankasi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Koninklijke Ten Cate NV:企業の戦略的SWOT分析
    Koninklijke Ten Cate NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • FirstString Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary FirstString Research Inc (FirstString) is a biopharmaceutical company that discovers and develops therapies for inflammation and injury based medical conditions. The company markets new therapeutic products that enable physicians to treat unmet medical need. It offers therapeutic approach, w …
  • H.B. Fuller Company:企業の戦略・SWOT・財務情報
    H.B. Fuller Company - Strategy, SWOT and Corporate Finance Report Summary H.B. Fuller Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rum Group for Transportation & Tourism Investment:企業の戦略・SWOT・財務情報
    Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report Summary Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Delta Apparel, Inc. (DLA):企業の財務・戦略的SWOT分析
    Delta Apparel, Inc. (DLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Merck KGaA:企業のM&A・事業提携・投資動向
    Merck KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Baumot Group AG (TINC):企業の財務・戦略的SWOT分析
    Baumot Group AG (TINC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • TransAtlantic Petroleum Ltd (TAT):石油・ガス:M&Aディール及び事業提携情報
    Summary TransAtlantic Petroleum Ltd. (TransAtlantic) is an upstream energy company that acquires, develops, explores for, and produces crude oil and natural gas. It holds interests in developed and undeveloped oil and natural gas properties in Turkey and Bulgaria. The company operates onshore explor …
  • Bucher Industries AG:企業の戦略・SWOT・財務情報
    Bucher Industries AG - Strategy, SWOT and Corporate Finance Report Summary Bucher Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆